Studies of the relationship between Runx2 and Galectin-3 demonstrated that Runx2 mediated the expression of Galectin-3 in skeletal tissue, human glioma cells, and human pituitary tumor [2,37,38]. This evidence concerns the gene LGALS3 and central nervous system cancer.